Literature DB >> 12601025

Incidence of blindness in southern Germany due to glaucoma and degenerative conditions.

Christoph Trautner1, Burkhard Haastert, Bernd Richter, Michael Berger, Guido Giani.   

Abstract

PURPOSE: To estimate population-based incidence rates of registered blindness separately, to determine its main causes.
METHODS: The files of all newly registered blindness-allowance recipients in Württemberg-Hohenzollern, Germany (population: approximately 5 million), between 1994 and 1998 were reviewed. From ophthalmological reports on file the fulfillment of the German criteria for blindness (visual acuity of 1/50 or less or equivalent reduction of visual function) was ascertained, and the causes of blindness were obtained. Incidence rates of blindness due to macular degeneration, glaucoma, cataract, optic atrophy, and diabetic retinopathy were estimated.
RESULTS: There were 3531 newly registered blindness-allowance recipients (67.1% female; mean age, 72.8 +/- 21.0 years). Standardized incidence rates in the general population (per 100,000 person-years; 95% confidence interval): All causes 12.27 (11.87-12.68), macular degeneration 5.29 (5.02-5.55), cataract 3.32 (3.11-3.52), optic atrophy 2.86 (2.66-3.05), glaucoma 2.43 (2.25-2.61), diabetic retinopathy 2.13 (1.96-2.30), other or unknown causes 5.17 (4.91-5.43). In many cases, blindness was attributable to more than one cause. Assuming that incidence rates are the same in other parts of the country, 9,939 (9,608-10,270) new cases of blindness were estimated to occur in Germany per year.
CONCLUSIONS: The most common single cause of blindness was macular degeneration. Incidence rates of blindness due to such treatable conditions as glaucoma were also high. This finding suggests that the taking of measures for secondary prevention (e.g., early detection and optimal treatment of patients with glaucoma and diabetic retinopathy) should be intensified.

Entities:  

Mesh:

Year:  2003        PMID: 12601025     DOI: 10.1167/iovs.02-0304

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

1.  [Spectrum of ophthalmologic and social rehabilitation at the Tübinger Low-Vision Clinic : a retrospective analysis for 1999-2005].

Authors:  N X Nguyen; M Weismann; S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

Review 2.  [Modern pharmacotherapy of age-related macular degeneration].

Authors:  F G Holz; H M Helb; A Bindewald-Wittich; H P N Scholl
Journal:  Internist (Berl)       Date:  2006-02       Impact factor: 0.743

3.  The Prevalence of Visual Impairment in the Adult Population.

Authors:  Christian Wolfram; Alexander K Schuster; Heike M Elflein; Stefan Nickels; Andreas Schulz; Philipp S Wild; Manfred E Beutel; Maria Blettner; Thomas Münzel; Karl J Lackner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2019-04-26       Impact factor: 5.594

Review 4.  [Diabetic maculopathy. Diagnosis and treatment].

Authors:  F Gelisken; F Ziemssen
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

5.  [Comparison of risk factors and guideline oriented prevention and therapy of diabetic retinopathy between type 2 diabetes patients undergoing laser therapy and type 2 diabetes outpatients].

Authors:  Ralf Paschke; Florian Gerhard Wuthe; Katja Kühn; Claudia Jochmann; Peter Wiedemann
Journal:  Med Klin (Munich)       Date:  2010-12-07

6.  Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.

Authors:  Michael Janusz Koss; Peter Kurz; Theoharis Tsobanelis; Walter Lehmacher; Cordula Fassbender; Reinhard Klingel; Frank H J Koch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-23       Impact factor: 3.117

7.  [Steroids for optic nerve diseases?].

Authors:  W A Lagrèze
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

8.  Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.

Authors:  Robert P Finger; Monika Fleckenstein; Frank G Holz; Hendrik P N Scholl
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

9.  Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy.

Authors:  Francesco Bandello; Albert Augustin; José-Alain Sahel; Hicham Benhaddi; Cristina Negrini; Klaus Hieke; Gilles H Berdeaux
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  [Blindness in Germany: dimensions and perspectives].

Authors:  R P Finger
Journal:  Ophthalmologe       Date:  2007-10       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.